MedTrace Logo

Efficacy of Combination Therapy With Minocycline for Treatment of Stenotrophomonas Maltophilia Infections

NCT05575427 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2023-01-10

No results posted yet for this study

Summary

The objective of the study is to evaluate the efficacy of minocycline for treatment Stenotrophomonas maltophilia infection. The hypothesis of study is the combination therapy with minocycline would be better than the monotherapy for treatment Stenotrophomonas maltophilia infection.

Conditions

  • Hospital Infections

Interventions

DRUG

Minocycline

The patients will receive minocycline oral between 7-28 days

DRUG

Levofloxacin or Cotrimoxazole

The patients will receive levofloxacin or cotrimoxazole oral between 7-28 days

DRUG

Placebo

Capsule without active compound

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Adhiratha Boonyasiri, MD · Department of research, Faculty of Medicine Siriraj hospital, Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-24
Primary Completion
2024-07-01
Completion
2024-11-01

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05575427 on ClinicalTrials.gov